SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Kezar Life Sciences Q1 EPS $(0.300) Up From $(0.400) YoY

Kezar Life Sciences (NASDAQ:KZR) reported quarterly losses of $(0.300) per share. This is a 25 percent increase over losses of $(0.400) per share from the same period last year.

Benzinga · 05/07/2020 20:16

Kezar Life Sciences (NASDAQ:KZR) reported quarterly losses of $(0.300) per share. This is a 25 percent increase over losses of $(0.400) per share from the same period last year.